Market Overview:
The global renal denervation equipment market is expected to grow at a CAGR of 10.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of hypertension, increasing number of clinical studies and trials on renal denervation, and growing demand for minimally invasive procedures. Based on type, the global renal denervation equipment market is segmented into enligHTN multi-electrode renal denervation system, Vessix Vascular (V2) renal denervation system, OneShot Renal Denervation System, PARADISE (Percutaneous Renal Denervation System), and others. Based on application, the global renal denvention equipment market is segmented into diagnostic centers and hospitals, research and academia institutions,, ambulatory care centers,, dialysis clinics,, nephrology clinics,, others). Geographically,. North America dominates the global renal devernation equipment market followed by Europe due To high prevalence of hypertension in these regions., Asia Pacific is projected to grow at highest CAGR during forecast period owing to increase in geriatric population which leads to rise in incidence rates of hypertension. Latin America holds significant share in terms revenue generated from sales of medical devices used for treatment or diagnosis purposes across different applications segments such as diagnostic centers & hospitals etc.
Product Definition:
Renal Denervation Equipment is a device used to surgically remove nerves from the kidney. This can be done to help control blood pressure in people who have high blood pressure that is not controlled by medications.
EnligHTN Multi-Electrode Renal Denervation System:
The global EnligHTN Multi-Electrode Renal Denervation System, it's usage and growth factor in the market for renal denervation equipment is expected to be significant over the forecast period. The rising number of patients suffering from chronic kidney diseases coupled with increasing R&D activities pertaining to minimally invasive surgeries are some of the factors attributing towards market growth.
Vessix Vascular (V2) Renal denervation System:
The Vessix vascular (V2) renal denervation system is used in the treatment of hypertension and renal disorders. It is a minimally invasive procedure that involves the destruction of small blood vessels supplying the kidney. The surgery takes about 45 to 90 minutes depending on which part of the kidney needs to be treated, and patients usually return to normal activities within a few days.
Application Insights:
Based on the application, the global renal denervation equipment market is segmented into diagnostic centers and hospitals, research and academia, ambulatory care centers, and others. The diagnostic center & hospital segment dominated the market in 2017 owing to a high prevalence of chronic kidney diseases (CKD) that require permanent renal denervation for effective treatment. According to U.S. National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), around 30-50 million people are affected by CKD globally which increases their risk of developing End-stage Renal Disease (ESRD). ESRD is a final stage when a patient cannot receive dialysis or any other form of artificial kidney function due to low functioning kidneys or an insufficient supply of blood vessels near the skin surface resulting in advanced stages such as hemodialysis or percutaneous nephrological interventions for treating them which boosts demand for R&D pertaining to permanent renal denervation techniques over there.
Regional Analysis:
North America dominated the global renal denervation equipment market in 2017. This can be attributed to increasing R&D investments by various companies, rising incidence of diabetes and hypertension, and growing adoption of advanced technologies for better patient care. Moreover, presence of well-established healthcare facilities and favorable reimbursement policies are also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure due to rise in disposable income coupled with increase in government initiatives for quality medical treatment at affordable prices.
Growth Factors:
- Increasing incidence of hypertension and renal diseases
- Growing demand for minimally invasive procedures
- Technological advancements in renal denervation equipment
- Rising healthcare expenditure by governments and private players
- Growing awareness about the benefits of renal denervation
Scope Of The Report
Report Attributes
Report Details
Report Title
Renal Denervation Equipment Market Research Report
By Type
EnligHTN Multi-Electrode Renal Denervation System, Vessix Vascular (V2) Renal denervation System, OneShot Renal Denervation System, PARADISE (Percutaneous Renal Denervation System), Others
By Application
Diagnostic Centers and Hospitals, Research and Academia, Ambulatory Care Centers, Others
By Companies
Abbott Laboratories, Ablative Solutions, Inc, Boston Scientific Corp, Cordis Corporation, Medtronic Inc, Mercator MedSystems, Inc, ReCor Medical, Inc, Symple Surgical Inc, Terumo Corporation, Abbott Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Renal Denervation Equipment Market Report Segments:
The global Renal Denervation Equipment market is segmented on the basis of:
Types
EnligHTN Multi-Electrode Renal Denervation System, Vessix Vascular (V2) Renal denervation System, OneShot Renal Denervation System, PARADISE (Percutaneous Renal Denervation System), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Centers and Hospitals, Research and Academia, Ambulatory Care Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Ablative Solutions, Inc
- Boston Scientific Corp
- Cordis Corporation
- Medtronic Inc
- Mercator MedSystems, Inc
- ReCor Medical, Inc
- Symple Surgical Inc
- Terumo Corporation
- Abbott Laboratories
Highlights of The Renal Denervation Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- EnligHTN Multi-Electrode Renal Denervation System
- Vessix Vascular (V2) Renal denervation System
- OneShot Renal Denervation System
- PARADISE (Percutaneous Renal Denervation System)
- Others
- By Application:
- Diagnostic Centers and Hospitals
- Research and Academia
- Ambulatory Care Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Renal Denervation Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Renal denervation equipment is a medical device that blocks the flow of blood to the kidneys. This can be done by severing the renal artery or vein, or by using a clamp to cut off the flow of blood.
Some of the key players operating in the renal denervation equipment market are Abbott Laboratories, Ablative Solutions, Inc, Boston Scientific Corp, Cordis Corporation, Medtronic Inc, Mercator MedSystems, Inc, ReCor Medical, Inc, Symple Surgical Inc, Terumo Corporation, Abbott Laboratories.
The renal denervation equipment market is expected to register a CAGR of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Renal Denervation Equipment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Renal Denervation Equipment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Renal Denervation Equipment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Renal Denervation Equipment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Renal Denervation Equipment Market Size & Forecast, 2018-2028
4.5.1 Renal Denervation Equipment Market Size and Y-o-Y Growth
4.5.2 Renal Denervation Equipment Market Absolute $ Opportunity
Chapter 5 Global Renal Denervation Equipment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Renal Denervation Equipment Market Size Forecast by Type
5.2.1 EnligHTN Multi-Electrode Renal Denervation System
5.2.2 Vessix Vascular (V2) Renal denervation System
5.2.3 OneShot Renal Denervation System
5.2.4 PARADISE (Percutaneous Renal Denervation System)
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Renal Denervation Equipment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Renal Denervation Equipment Market Size Forecast by Applications
6.2.1 Diagnostic Centers and Hospitals
6.2.2 Research and Academia
6.2.3 Ambulatory Care Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Renal Denervation Equipment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Renal Denervation Equipment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Renal Denervation Equipment Analysis and Forecast
9.1 Introduction
9.2 North America Renal Denervation Equipment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Renal Denervation Equipment Market Size Forecast by Type
9.6.1 EnligHTN Multi-Electrode Renal Denervation System
9.6.2 Vessix Vascular (V2) Renal denervation System
9.6.3 OneShot Renal Denervation System
9.6.4 PARADISE (Percutaneous Renal Denervation System)
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Renal Denervation Equipment Market Size Forecast by Applications
9.10.1 Diagnostic Centers and Hospitals
9.10.2 Research and Academia
9.10.3 Ambulatory Care Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Renal Denervation Equipment Analysis and Forecast
10.1 Introduction
10.2 Europe Renal Denervation Equipment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Renal Denervation Equipment Market Size Forecast by Type
10.6.1 EnligHTN Multi-Electrode Renal Denervation System
10.6.2 Vessix Vascular (V2) Renal denervation System
10.6.3 OneShot Renal Denervation System
10.6.4 PARADISE (Percutaneous Renal Denervation System)
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Renal Denervation Equipment Market Size Forecast by Applications
10.10.1 Diagnostic Centers and Hospitals
10.10.2 Research and Academia
10.10.3 Ambulatory Care Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Renal Denervation Equipment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Renal Denervation Equipment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Renal Denervation Equipment Market Size Forecast by Type
11.6.1 EnligHTN Multi-Electrode Renal Denervation System
11.6.2 Vessix Vascular (V2) Renal denervation System
11.6.3 OneShot Renal Denervation System
11.6.4 PARADISE (Percutaneous Renal Denervation System)
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Renal Denervation Equipment Market Size Forecast by Applications
11.10.1 Diagnostic Centers and Hospitals
11.10.2 Research and Academia
11.10.3 Ambulatory Care Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Renal Denervation Equipment Analysis and Forecast
12.1 Introduction
12.2 Latin America Renal Denervation Equipment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Renal Denervation Equipment Market Size Forecast by Type
12.6.1 EnligHTN Multi-Electrode Renal Denervation System
12.6.2 Vessix Vascular (V2) Renal denervation System
12.6.3 OneShot Renal Denervation System
12.6.4 PARADISE (Percutaneous Renal Denervation System)
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Renal Denervation Equipment Market Size Forecast by Applications
12.10.1 Diagnostic Centers and Hospitals
12.10.2 Research and Academia
12.10.3 Ambulatory Care Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Renal Denervation Equipment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Renal Denervation Equipment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Renal Denervation Equipment Market Size Forecast by Type
13.6.1 EnligHTN Multi-Electrode Renal Denervation System
13.6.2 Vessix Vascular (V2) Renal denervation System
13.6.3 OneShot Renal Denervation System
13.6.4 PARADISE (Percutaneous Renal Denervation System)
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Renal Denervation Equipment Market Size Forecast by Applications
13.10.1 Diagnostic Centers and Hospitals
13.10.2 Research and Academia
13.10.3 Ambulatory Care Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Renal Denervation Equipment Market: Competitive Dashboard
14.2 Global Renal Denervation Equipment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Ablative Solutions, Inc
14.3.3 Boston Scientific Corp
14.3.4 Cordis Corporation
14.3.5 Medtronic Inc
14.3.6 Mercator MedSystems, Inc
14.3.7 ReCor Medical, Inc
14.3.8 Symple Surgical Inc
14.3.9 Terumo Corporation
14.3.10 Abbott Laboratories
